Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
21.05.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 21.05.2024 | 2.641 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 21.05.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 21.05.2024.ISIN NameCA00379L1067 ABRASILV.... ► Artikel lesen | |
MOTUS GI Aktie jetzt für 0€ handeln | |||||
18.03.24 | Motus GI Holdings, Inc.: Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update | 267 | GlobeNewswire (Europe) | Initiated limited U.S. commercial launch of the Pure-Vu® EVS Gastro and Gen 4 Colon system, including successful UGI procedures at several leading hospital systemsThe Company is engaged in the process... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MEDTRONIC | 87,37 | +0,29 % | Medtronic plc: Medtronic announces cash dividend for fourth quarter of fiscal year 2025 | GALWAY, Ireland, March 6, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, March 6, 2025, approved the company's cash dividend... ► Artikel lesen | |
INTUITIVE SURGICAL | 477,10 | -0,10 % | Intuitive Surgical Aktie: Das sagen aktuelle Marktberichte | Der Aktienkurs von Intuitive Surgical zeigt sich am 01. März 2025 mit einem Kurs von 552,45 EUR nahezu unverändert gegenüber dem Vortag. Trotz eines Monatsverlusts von 1,80% verzeichnet der führende... ► Artikel lesen | |
ROKU | 69,51 | -1,67 % | Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip | ||
ATOSSA THERAPEUTICS | 0,670 | -1,03 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Responds to PTAB Ruling on U.S. Patent No. 11,572,334 and Announces the Issuance of U.S. Patent No. 12,201,591 | SEATTLE, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment... ► Artikel lesen | |
EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 | - Improved loss from operations by 31% -
- Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health... ► Artikel lesen | |
SONOMA PHARMACEUTICALS | 2,520 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando | BOULDER, CO / ACCESS Newswire / February 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
CYTOSORBENTS | 0,942 | -8,19 % | Cytosorbents Corp - 8-K, Current Report | ||
QUIDELORTHO | 36,000 | -4,76 % | QuidelOrtho Corp - 8-K, Current Report | ||
CENTENE | 55,57 | +0,43 % | Here's How Much You Would Have Made Owning Centene Stock In The Last 20 Years | ||
VERU | 0,496 | +5,35 % | Veru Inc.: Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress | --Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 0,775 | +1,37 % | Tempest Therapeutics: Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma | Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC Amezalpat builds momentum with both Fast Track and Orphan Drug Designations BRISBANE, Calif.... ► Artikel lesen | |
ONTRAK | 1,420 | -0,70 % | Ontrak Health Announces 2024 Third Quarter Financial Results | MIAMI--(BUSINESS WIRE)--Ontrak, Inc. (NASDAQ: OTRK) ("Ontrak" or the "Company"), a leading AI-powered and technology-enabled behavioral healthcare company, today reported its financial results... ► Artikel lesen | |
SENSEONICS | 0,530 | -10,35 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results | Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, Ascensia Patient base increased 56% in 2024 over 2023 to approximately... ► Artikel lesen | |
NANO-X IMAGING | 6,050 | -1,22 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives CE Mark, Expanding Medical Imaging Offering in European Market | CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use FDA clearance in the U.S.New clinical data supporting use of Nanox.ARC... ► Artikel lesen | |
PATTERSON COMPANIES | 28,800 | 0,00 % | Clark Estates Inc. NY Purchases New Position in Patterson Companies, Inc. (NASDAQ:PDCO) |